Clinical Trials
11 trialsNCT05997342 2025-08-11
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT06344351 2025-05-22
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT06297642 2024-08-06
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Terminated
NCT06165809 2023-12-29
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Withdrawn
NCT06165822 2023-12-12
A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT05867563 2023-07-10
Clinical Trial Evaluating the Safety of the TQB2103 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT03088527 2022-08-18
Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer
Stemline Therapeutics, Inc.
Phase 1 Completed
NCT03051035 2021-09-20
First-in-Human Study of KO-947 in Non-Hematological Malignancies
Kura Oncology, Inc.
Phase 1 Terminated
NCT01125891 2017-06-23
Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors
Traws Pharma, Inc.
Phase 1 Completed
NCT00692159 2010-09-10
Study of TRC102 in Combination With Pemetrexed in Cancer Patients
Tracon Pharmaceuticals Inc.
Phase 1 Completed